Efficacy and safety of ragweed sublingual immunotherapy in Canadian patients with allergic rhinoconjunctivitis

BACKGROUND: Currently accepted therapies for ragweed allergy in North America consist of pharmacotherapy and subcutaneous allergen immunotherapy injections to treat symptoms. Allergen immunotherapy not only reduces symptoms and the need for pharmacotherapy but has also been shown to have disease-mod...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Allergy Asthma Clin Immunol
Autors principals: Kim, Harold, Waserman, Susan, Hébert, Jacques, Blaiss, Michael, Nelson, Harold, Creticos, Peter, Kaur, Amarjot, Maloney, Jennifer, Li, Ziliang, Nolte, Hendrik
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2014
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4363352/
https://ncbi.nlm.nih.gov/pubmed/25788949
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1710-1492-10-55
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars